ARMISTICE CAPITAL, LLC
Top Portfolio Positions
300 positions ·
$5,041,832,852 total
· as of Sep 30, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
2,500,000 | $1,665,450,000 | 33.03% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
3,277,272 | $201,126,182 | 3.99% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
6,724,000 | $160,703,600 | 3.19% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
2,836,000 | $135,532,440 | 2.69% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
2,146,868 | $117,991,865 | 2.34% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
249,982 | $114,656,744 | 2.27% | |
| INCY |
Incyte Corp
Healthcare
|
1,167,431 | $99,009,823 | 1.96% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
697,022 | $97,847,948 | 1.94% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
5,836,000 | $94,076,320 | 1.87% | |
| XRAY |
DENTSPLY SIRONA Inc.
Healthcare
|
5,736,000 | $72,789,840 | 1.44% |
Portfolio Trend
23 quarters · across all stocks
No Holdings History
No holdings records found for this institution in REED.